as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
2.34%
Downside
2.34%
Upside
52 Week's Low
52 Week's High
58.82%
Downside
300.69%
Upside
Check Ironwood Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$212.8M
EPS (TTM)
0.21
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.77%
PE Ratio (TTM)
88.61
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
-0.26
EBITDA
93.7M
Revenue (TTM)
308.5M
Profit Margin
-2.56%
Return On Equity TTM
0.00%
Track how Ironwood Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Ironwood Pharmaceuticals, Inc. in the last 5 years
Lowest (9.68x)
June 30, 2023
Industry (-3.85x)
September 15, 2025
Today (88.61x)
September 15, 2025
Highest (129.55x)
June 30, 2024
Today’s Price to Earnings Ratio: 88.61x
Compare market cap, revenue, PE, and other key metrics of Ironwood Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $212.8M | -87.09% | 88.61 | -2.56% | |
BUY | $18.3B | NA | 15.8 | 40.36% | |
BUY | $44.1B | NA | 21.8 | 13.81% | |
BUY | $14.1B | 36.02% | 41.97 | 13.88% | |
BUY | $65.7B | -8.68% | 25.51 | 27.83% |
The Ironwood Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ironwood Pharmaceuticals, Inc. investment value today
Current value as on today
₹32,994
Returns
Returns from Ironwood Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,985 (+4.99%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Ironwood Pharmaceuticals, Inc.. Average target price of $0.95
Get share price movements and forecasts by analysts on Ironwood Pharmaceuticals, Inc..
What analysts predicted
-34.74%DOWNSIDE
Target Price
$0.95
Current Price
$1.28
Analyzed by
12 Analysts
Target
$0.95
Ironwood Pharmaceuticals, Inc. target price $0.95, a slight downside of -34.74% compared to current price of $1.28. According to 12 analysts rating.
Search interest for Ironwood Pharmaceuticals, Inc. Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, IRWD stock has moved up by 15.9%
Revenue Rich
Revenue is up for the last 2 quarters, 41.14M → 85.23M (in $), with an average increase of 51.7% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -37.38M → 23.59M (in $), with an average increase of 258.4% per quarter
Against Peers
In the last 3 years, United Therapeutics Corporation has given 83.6% return, outperforming this stock by 171.6%
Against Peers
In the last 1 year, United Therapeutics Corporation has given 19.4% return, outperforming this stock by 90.7%
Organisation | Ironwood Pharmaceuticals, Inc. |
Headquarters | 100 Summer Street, Boston, MA, United States, 02110 |
Industry | Health Technology |
CEO | Mr. Thomas A. McCourt |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. John Minardo | Senior VP, Chief Legal Officer & Secretary |
Dr. Michael Shetzline M.D., Ph.D. | Chief Medical Officer, Senior VP and Head of Research & Drug Development |
Mr. Gregory Martini | Senior VP, CFO & Investor Relations |
Mr. Ronald Silver | Senior VP, Corporate Controller & Principal Accounting Officer |
Dr. Rosario Lobrutto M.B.A., M.S., Ph.D. | VP & Global Head of Technical Operations |
Ms. Tammi Gaskins | Senior Vice President & Chief Commercial Officer. |
Mr. Jeff Ruberti | Chief Strategy Officer |
Mr. Thomas A. McCourt | CEO & Director |
Ironwood Pharmaceuticals, Inc. share price today is $1.28 as on at the close of the market. Ironwood Pharmaceuticals, Inc. share today touched a day high of $1.31 and a low of $1.25.
Ironwood Pharmaceuticals, Inc. share touched a 52 week high of $5.13 on and a 52 week low of $0.53 on . Ironwood Pharmaceuticals, Inc. stock price today i.e. is closed at $1.28,which is 75.04% down from its 52 week high and 142.84% up from its 52 week low.
Ironwood Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Ironwood Pharmaceuticals, Inc. (IRWD) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Ironwood Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ironwood Pharmaceuticals, Inc. share’s latest price of $1.28 as on September 16, 2025 at 1:29 am IST, you will get 7.8125 shares of Ironwood Pharmaceuticals, Inc.. Learn more about
fractional shares .
Ironwood Pharmaceuticals, Inc. stock has given -87.09% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?